What are Platelet Aggregation Devices?
What are Platelet Aggregation
Devices?
Platelet aggregation is the procedure in which the platelets
are clomped together in the blood which leads to the formation of a thrombus or
clot. The devices involved in the aggregation of platelets are termed as
platelet aggregation devices market. The aggrometers, one of the medical device
used in platelet aggregation, works against the clotting, to further stop the
clot formation. This process is used for the diagnosis and identification of
the defects in platelet functions.
What is the Platelet Aggregation Devices Market?
The global platelet aggregation devices market was valued at
USD 365.54 million in 2021, growing at a CAGR of 7.85% during the forecast
period from 2022 to 2027 to reach USD 573.25 million by 2027. The platelet
aggregation devices market is witnessing positive growth owing to various
factors such as the rising prevalence of cardiovascular, hematological, and
other target disorders and surging burden of geriatric population across the
globe. Further, technological advancements in platelet aggregometers, for instance
accurate and automatic testing of platelets and other advancements will
increase the demand of the device in the forthcoming years. Additionally, the
rise in the number of industry-academia collaborations and clinical studies in
the healthcare industry will also contribute in the growth of platelet
aggregation devices market. Also, the increasing regulatory approvals and
launches across the globe will further increase the overall growth of the
platelet aggregation devices market. Therefore, the market for platelet
aggregation devices market is estimated to grow at a significant CAGR during
the forecast period from 2022 to 2027.
Know which Platelet Aggregation
Devices is expected to score the touchdown first @ Platelet Aggregation Devices Market Size
What is the Platelet
Aggregation Devices Market Dynamics?
One of the main driver for the platelet aggregation devices
market is the increasing figures of bleeding and haematological disorders. For
instance, the National Organization for Rare Disorders (NORD) stated in a
latest study the incidence of adult Immune thrombocytopenia (ITP) in the United
States was roughly estimated to be 3.3 per 100,000/year. Also, the prevalence
od ITP was reported to be 9.5 per 100,000. Further, in a study done by the
Maryland Health Care Commission (2021), the prevalence of ITP was estimated to
be 9.5 per 100,000 children ages 1-5, 7.3 per 100,000 in children ages 6-10,
and 4.1 per 100,000 in children of ages 11-14, in 2021, in the United States.
COVID-19 Impact on
the Platelet Aggregation Devices Market
The COVID-19 pandemic has negatively impacted the market for
platelet aggregation devices market. The outbreak of the pandemic led to the
cancellation of outpatient visits and the suspension of non-emergency hospitals
and surgical procedures for chronic disorders such as cancers, diabetes,
cardiovascular disorders, and others. Moreover, the number of diagnostic tests
many disorders were reduced as the priority was given to the covid-19 testing.
Further, due to imposition of strict lockdown rules the manufacturing of the
devices was ceased. However, vaccine development of COVID-19 has produced the
process of economic recovery with the easing of lockdown restrictions and the
return of normalcy in the economic landscape which has initiated the process of
resumption of regular healthcare services, diagnostic tests, and surgical
procedures for the treatment and management of various diseases ultimately
increasing the demand of platelet aggregation devices market, thereby bringing
the demand for device on track in the platelet aggregation devices market.
Learn more for Platelet
Aggregation Devices Market Research Report @ Platelet Aggregation Devices Market Share
What are the drivers
for the Platelet Aggregation Devices market?
The platelet aggregation devices market is observing an
affirmative market growth owing to the factors such as rising prevalence of
cardiovascular, haematological, and other target disorders, surging burden of
geriatric population, technological advancements in platelet aggregometers,
rise in the number of industry-academia collaborations and clinical studies,
and the upsurge in the regulatory approvals for platelet aggregation devices
market.
Who are the Platelet Aggregation Devices Market Companies?
Some of the key market players operating in the platelet
aggregation devices market include F. Hoffmann-La Roche Ltd, Werfen, Drucker
Diagnostics, Haemonetics Corporation, Sienco, Inc., BIO/DATA CORPORATION,
AggreDYNE, Siemens Healthcare Private Limited, Chrono-log Corporation, Grifols,
S.A., Helena Laboratories Corporation., SENTINEL. Sysmex Corporation, Matis
Medical Inc., Elektronik GmbH & Co., and others.
For further
information of the Platelet Aggregation Devices market report @ Platelet Aggregation Devices Market Forecast
Which region has the
highest share in Platelet Aggregation Devices Market?
North America is expected to dominate the global platelet
aggregation devices market. Factors contributing to the growth are the rising
number of cardiovascular surgeries, rising number of orthopaedic, urological,
bleeding, and disorders, escalating burden of geriatric patients, and others
which are contributing to the growth of the platelet aggregation devices market
in the North America region.
Latest Market Research Reports 2022 by DelveInsight
- Erosive Hand Osteoarthritis Market
- CXCR Inhibitors Market
- Stem Cell Market
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Market
- Oncolytic Virus Cancer Therapy Pipeline
- Surgical Sealant Market
- Superficial Punctate Keratitis
- Medical Marijuana Market
- Immune Checkpoints Activators Market
About Us
DelveInsight is a Business Consulting and Market research company, providing expert business solutions for the healthcare domain and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.
Contact Us
Yash Bhardwaj
info@delveinsight.com
Comments
Post a Comment